JUBEREQ

LIVE

Serial Number

79391361

Owner

Accord Healthcare Limited

Attorney

Michele K. Robichaux

Filing Date

Jan 15, 2024

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

JUBEREQ Trademark

Serial Number: 79391361 • Registration: 7772704

JUBEREQ is a trademark filed by Accord Healthcare Limited on January 15, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Accord Healthcare Limited (8 trademarks)

Sage House, 319 Pinner Road

Entity Type: 99

ACCORD BIOPHARMA, INC. (28 trademarks)

1009 SLATER ROAD, SUITE 210
DURHAM, NC 27703

Entity Type: 03

Legal Representation

Attorney of Record

Michele K. Robichaux

426 trademarks filed View all →

Correspondence Address

Michele K. Robichaux Odin Law and Media

4208 Six Forks Rd., STE 1000

Raleigh, NC 27609

United States

Trademark Details

Filing Date

January 15, 2024

Registration Date

April 29, 2025

Published for Opposition

March 11, 2025

Goods & Services

pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB

Dec 18, 2025 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Nov 19, 2025 FICS

FINAL DISPOSITION PROCESSED

Nov 19, 2025 FIMP

CHANGE OF OWNER RECEIVED FROM IB

Sep 25, 2025 DCPN

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Sep 5, 2025 OPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Aug 13, 2025 OPNS

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Aug 13, 2025 OPNR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jul 29, 2025 FICR

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 29, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Apr 29, 2025 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 11, 2025 NPUB

PUBLISHED FOR OPPOSITION

Mar 11, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 5, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 14, 2025 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 13, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 13, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 13, 2025 TROA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Feb 7, 2025 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Feb 7, 2025 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Feb 7, 2025 REAP

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Feb 7, 2025 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Feb 7, 2025 COAR

REFUSAL PROCESSED BY IB

Sep 9, 2024 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Aug 21, 2024 RFCS

REFUSAL PROCESSED BY MPU

Aug 21, 2024 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Aug 14, 2024 RFCR

NON-FINAL ACTION WRITTEN

Aug 13, 2024 CNRT

ASSIGNED TO EXAMINER

Aug 9, 2024 DOCK

APPLICATION FILING RECEIPT MAILED

Apr 24, 2024 MAFR

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 24, 2024 NWOS

SN ASSIGNED FOR SECT 66A APPL FROM IB

Mar 14, 2024 REPR

Related Trademarks

More from this Owner

FILKRI

ACCORD BIOPHARMA

More in Same Class

VEXOLYN

ST. JAMES THERAPEUTICS

Serial #79392431

SERB PHARMACEUTICALS

UIAIU

OSVYRTI